These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 32399619)
1. [Treatment of giant cell arteritis: what is in the pipeline?]. Holle JU; Moosig F Z Rheumatol; 2020 Aug; 79(6):516-522. PubMed ID: 32399619 [TBL] [Abstract][Full Text] [Related]
2. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature. Kötter I; Henes JC; Wagner AD; Loock J; Gross WL Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655 [TBL] [Abstract][Full Text] [Related]
3. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study. Kreis L; Dejaco C; Schmidt WA; Németh R; Venhoff N; Schäfer VS Trials; 2024 Jan; 25(1):56. PubMed ID: 38225579 [TBL] [Abstract][Full Text] [Related]
4. Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index. Berti A; Cornec D; Medina Inojosa JR; Matteson EL; Murad MH Semin Arthritis Rheum; 2018 Aug; 48(1):77-82. PubMed ID: 29496228 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future. Hellmich B; Águeda AF; Monti S; Luqmani R Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642 [TBL] [Abstract][Full Text] [Related]
6. The role of biologics in the treatment of giant cell arteritis. González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S Expert Opin Biol Ther; 2019 Jan; 19(1):65-72. PubMed ID: 30513026 [TBL] [Abstract][Full Text] [Related]
7. Treatment of giant cell arteritis. González-Gay MÁ; Pina T; Prieto-Peña D; Calderon-Goercke M; Gualillo O; Castañeda S Biochem Pharmacol; 2019 Jul; 165():230-239. PubMed ID: 31034796 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of giant cell arteritis]. Samson M; Greigert H; Ghesquière T; Bonnotte B Presse Med; 2019 Sep; 48(9):968-979. PubMed ID: 31324351 [TBL] [Abstract][Full Text] [Related]
9. Current and emerging diagnosis tools and therapeutics for giant cell arteritis. González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748 [TBL] [Abstract][Full Text] [Related]
19. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases. Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427 [TBL] [Abstract][Full Text] [Related]
20. Need and value of targeted immunosuppressive therapy in giant cell arteritis. Sandovici M; van der Geest N; van Sleen Y; Brouwer E RMD Open; 2022 Feb; 8(1):. PubMed ID: 35149602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]